ZEISS and RIKEN Innovation Co., Ltd. entered into a strategic collaboration agreement to jointly explore opportunities in aiming to identify projects where the combination of RIKEN’s expertise in bioengineering and image data manipulation and ZEISS’ leadership in optical solutions can accelerate bioengineering innovations and bring about a paradigm change in health care.
“We are proud to complement RIKEN’s broad-spectrum and extensive basic research through our expertise in biomedical imaging, which we see as a fundamental ingredient for turning bioengineering into viable healthcare solutions. The success of leading-edge research requires not only groundbreaking ideas but also access and management of advanced scientific equipment. Highest level of instrument availability and advanced image data management are key to efficient R&D”, said Dr. Stefan Sacré, Head of ZEISS in Japan.
RIKEN’s extensive R&D infrastructure and imaging resources provide an excellent base for collaboration between RIKEN and ZEISS. Hiroshi Matsumoto, President of RIKEN, commented, “Today’s Agreement with ZEISS, a corporation which has earned a high level of trust world-wide as a manufacturer of high-precision microscopes and optical instruments, represents a new kind of partnership that does not merely focus on separate research topics. I look forward to an environment in which our partners at ZEISS and researchers at RIKEN engage in free and open discussions, and for RIKEN Innovation to support both organizations in their strategic planning. I expect that this will lead to collaborative research activity of the highest level and the pioneering of new fields.”